Education
About Us
Working with TipRanks
Follow Us
Adverum Biotechnologies (ADVM)
NASDAQ:ADVM
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 1.00M | $ 3.60M | $ 0.00 | $ 7.50M | $ 0.00 |
| Gross Profit | $ -2.65M | $ -2.04M | $ -6.53M | $ 2.85M | $ -4.16M |
| Operating Income | $ -139.16M | $ -123.99M | $ -157.13M | $ -146.12M | $ -117.95M |
| EBITDA | $ -127.27M | $ -118.35M | $ -147.93M | $ -140.90M | $ -112.23M |
| Net Income | $ -130.93M | $ -117.17M | $ -154.54M | $ -145.54M | $ -117.51M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 125.69M | $ 96.53M | $ 185.59M | $ 305.19M | $ 429.73M |
| Total Assets | $ 179.84M | $ 173.01M | $ 308.37M | $ 439.73M | $ 482.57M |
| Total Debt | $ 91.70M | $ 75.04M | $ 106.80M | $ 102.99M | $ 30.71M |
| Net Debt | $ 31.05M | $ 36.00K | $ 38.37M | $ 68.80M | $ -31.72M |
| Total Liabilities | $ 109.13M | $ 89.54M | $ 126.85M | $ 123.54M | $ 48.22M |
| Stockholders' Equity | $ 70.71M | $ 83.47M | $ 181.52M | $ 316.19M | $ 434.35M |
| Cash Flow | |||||
| Free Cash Flow | $ -92.85M | $ -91.71M | $ -119.91M | $ -122.95M | $ -91.14M |
| Operating Cash Flow | $ -92.46M | $ -90.90M | $ -108.09M | $ -107.83M | $ -79.29M |
| Investing Cash Flow | $ -41.89M | $ 96.88M | $ 141.72M | $ 78.71M | $ -280.17M |
| Financing Cash Flow | $ 120.00M | $ 69.00K | $ 607.00K | $ 2.40M | $ 355.99M |